These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21750517)

  • 1. Viral hepatitis: Ciclosporin versus tacrolimus for HCV transplant recipients.
    Berenguer M
    Nat Rev Gastroenterol Hepatol; 2011 Jul; 8(8):422-4. PubMed ID: 21750517
    [No Abstract]   [Full Text] [Related]  

  • 2. Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection.
    Yoshida EM; Lilly LB; Marotta PJ; Mason AL; Bilodeau M; Vaillancourt M
    Ann Hepatol; 2013; 12(2):282-93. PubMed ID: 23396740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retransplantation for recurrent hepatitis C following tacrolimus or cyclosporine immunosuppression.
    Ghobrial RM; Colquhoun S; Rosen H; Hollis P; Ponthieux S; Pakrasi A; Farmer DG; Markman JF; Markowitz J; Drazan K; Yersiz H; Singer J; Stribling R; Arnout W; Holt CD; Goss J; Imagawa D; Seu P; Goldstein LI; Shackleton CR; Martin P; Busuttil RW
    Transplant Proc; 1998 Jun; 30(4):1470-1. PubMed ID: 9636597
    [No Abstract]   [Full Text] [Related]  

  • 4. A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C.
    Jain A; Kashyap R; Demetris AJ; Eghstesad B; Pokharna R; Fung JJ
    Liver Transpl; 2002 Jan; 8(1):40-6. PubMed ID: 11799484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cyclosporine-based immunosuppressive regimen may be better than tacrolimus for long-term liver allograft survival in recipients transplanted for hepatitis C.
    Rayhill SC; Barbeito R; Katz D; Voigt M; Labrecque D; Kirby P; Miller R; Stolpen A; Wu Y; Schmidt W
    Transplant Proc; 2006 Dec; 38(10):3625-8. PubMed ID: 17175350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents--a potentially lethal cocktail.
    Charlton M
    Hepatology; 2011 Jul; 54(1):3-5. PubMed ID: 21710471
    [No Abstract]   [Full Text] [Related]  

  • 7. Sustained virological response to antiviral therapy in a randomized trial of cyclosporine versus tacrolimus in liver transplant patients with recurrent hepatitis C infection.
    Duvoux C; Villamil F; Renner EL; Grazi GL; Firpi RJ; Pageaux G; Mulhaupt B; Schirm F; Rauer B; Bernhardt P; Levy G
    Ann Transplant; 2015 Jan; 20():25-35. PubMed ID: 25588713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of calcineurin inhibitors on hepatitis C recurrence after liver transplantation.
    Kim RD; Mizuno S; Sorensen JB; Schwartz JJ; Fujita S
    Dig Dis Sci; 2012 Feb; 57(2):568-72. PubMed ID: 21881974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of tacrolimus versus cyclosporine in hepatitis C virus-infected liver transplant recipients on recurrent hepatitis: a prospective, randomized trial.
    Martin P; Busuttil RW; Goldstein RM; Crippin JS; Klintmalm GB; Fitzsimmons WE; Uleman C
    Liver Transpl; 2004 Oct; 10(10):1258-62. PubMed ID: 15376310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes in liver transplant patients with hepatic C infection receiving tacrolimus or cyclosporine.
    Villamil F; Levy G; Grazi GL; Mies S; Samuel D; Sanjuan F; Rossi M; Lake J; Munn S; Mühlbacher F; Leonardi L; Cillo U
    Transplant Proc; 2006 Nov; 38(9):2964-7. PubMed ID: 17112875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up in hepatitis C patients with respect to immunosuppression.
    Mueller AR; Platz KP; Berg T; Fukomoto T; Guckelberger O; Neuhaus R; Bechstein WO; Hopf U; Lobeck H; Neuhaus P
    Transplant Proc; 1996 Dec; 28(6):3241-2. PubMed ID: 8962255
    [No Abstract]   [Full Text] [Related]  

  • 12. Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients.
    Handisurya A; Kerscher C; Tura A; Herkner H; Payer BA; Mandorfer M; Werzowa J; Winnicki W; Reiberger T; Kautzky-Willer A; Pacini G; Säemann M; Schmidt A
    PLoS One; 2016; 11(1):e0145319. PubMed ID: 26735686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of tacrolimus with microemulsion cyclosporine as primary immunosuppression in hepatitis C patients after liver transplantation.
    Zervos XA; Weppler D; Fragulidis GP; Torres MB; Nery JR; Khan MF; Pinna AD; Kato T; Miller J; Reddy KR; Tzakis AG
    Transplantation; 1998 Apr; 65(8):1044-6. PubMed ID: 9583863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of antiviral therapy for hepatitis C after liver transplantation with cyclosporine and tacrolimus: a systematic review and meta-analysis.
    Rabie R; Mumtaz K; Renner EL
    Liver Transpl; 2013 Jan; 19(1):36-48. PubMed ID: 22821730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of tacrolimus with cyclosporin as primary immunosuppression in patients with hepatitis C virus infection after liver transplantation.
    Ben-Ari Z; Mor E; Bar-Nathan N; Shaharabani E; Shapira Z; Tur-Kaspa R
    Transplant Proc; 2003 Mar; 35(2):612-3. PubMed ID: 12644067
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatitis C virus viral load after conversion from tacrolimus to cyclosporine in liver transplant patients: a pilot study.
    Guitard J; Sandres-Sauné K; Kamar N; Ribes D; Faguer S; Esposito L; Lavit M; Muscari F; Péron JM; Lavayssière L; Durand D; Rostaing L
    Transplant Proc; 2007 Oct; 39(8):2603-5. PubMed ID: 17954189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved liver function and decreased hepatitis C viral load after tacrolimus was replaced by cyclosporine.
    Lorho R; Turlin B; de Lajarte-Thirouard AS; Camus C; Lakehal M; Compagnon P; Meunier B; Boudjema K; Messner M
    Transplant Proc; 2005; 37(6):2871-2. PubMed ID: 16182838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid-free induction and preemptive antiviral therapy for liver transplant recipients with hepatitis C: a preliminary report from a prospective randomized study.
    Kato T; Yoshida H; Sadfar K; Martinez E; Nishida S; Moon J; Madariaga J; Selvaggi G; Levi D; Ruiz P; Schiff E; Tzakis A
    Transplant Proc; 2005 Mar; 37(2):1217-9. PubMed ID: 15848674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppression and outcomes of patients transplanted for hepatitis C.
    Lake JR
    J Hepatol; 2006 Apr; 44(4):627-9. PubMed ID: 16503080
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporine versus tacrolimus in patients with HCV infection after liver transplantation: effects on virus replication and recurrent hepatitis.
    Hilgard P; Kahraman A; Lehmann N; Seltmann C; Beckebaum S; Ross RS; Baba HA; Malago M; Broelsch CE; Gerken G
    World J Gastroenterol; 2006 Feb; 12(5):697-702. PubMed ID: 16521181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.